Revenio Group Oyj
OMXH:REG1V
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
22.48
35.7
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one REG1V stock under the Base Case scenario is 30.94 EUR. Compared to the current market price of 28.96 EUR, Revenio Group Oyj is Undervalued by 6%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Revenio Group Oyj
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for REG1V cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Revenio Group Oyj
Balance Sheet Decomposition
Revenio Group Oyj
Current Assets | 48.3m |
Cash & Short-Term Investments | 21.5m |
Receivables | 12.6m |
Other Current Assets | 14.3m |
Non-Current Assets | 89.1m |
Long-Term Investments | 2.3m |
PP&E | 5.9m |
Intangibles | 78.1m |
Other Non-Current Assets | 2.8m |
Current Liabilities | 21.2m |
Accounts Payable | 12.4m |
Other Current Liabilities | 8.8m |
Non-Current Liabilities | 16.3m |
Long-Term Debt | 12.4m |
Other Non-Current Liabilities | 4m |
Earnings Waterfall
Revenio Group Oyj
Revenue
|
96.6m
EUR
|
Cost of Revenue
|
-47.5m
EUR
|
Gross Profit
|
49.1m
EUR
|
Operating Expenses
|
-22.8m
EUR
|
Operating Income
|
26.3m
EUR
|
Other Expenses
|
-7.2m
EUR
|
Net Income
|
19.1m
EUR
|
Free Cash Flow Analysis
Revenio Group Oyj
EUR | |
Free Cash Flow | EUR |
In Q2, the company's net sales increased by 14.2% to EUR 25.4 million, benefiting from strong performances in both the U.S. and EMEA regions. Fundus imaging devices and tonometers were top sellers, with new product launches like the iCare tonometer PRO showing promising sales. Operating profit rose by 12.6% to EUR 5.3 million. The company maintains its full-year guidance of 5% to 10% revenue growth. Despite personnel and clinical trial costs, cash flow was excellent at EUR 11 million for H1, and the equity ratio is strong at nearly 75%. The EBITDA for H1 also saw a boost to EUR 13.3 million.
What is Earnings Call?
REG1V Profitability Score
Profitability Due Diligence
Revenio Group Oyj's profitability score is 67/100. The higher the profitability score, the more profitable the company is.
Score
Revenio Group Oyj's profitability score is 67/100. The higher the profitability score, the more profitable the company is.
REG1V Solvency Score
Solvency Due Diligence
Revenio Group Oyj's solvency score is 89/100. The higher the solvency score, the more solvent the company is.
Score
Revenio Group Oyj's solvency score is 89/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
REG1V Price Targets Summary
Revenio Group Oyj
According to Wall Street analysts, the average 1-year price target for REG1V is 31.15 EUR with a low forecast of 28.28 EUR and a high forecast of 34.65 EUR.
Dividends
Current shareholder yield for REG1V is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Revenio Group Oyj is a globally operating health technology, which engages in the detection of glaucoma, osteoporosis, skin cancer, and asthma. The company is headquartered in Vantaa, Etela-Suomen and currently employs 184 full-time employees. The company went IPO on 2003-01-01. The Company’s activities are divided into two business areas: Revenio Health Tech, which is responsible for the design, manufacture and sale of tonometers and bone density measurement devices; as well as Revenio Technology and Services, which provides contact center services for material handling systems. The company distributes products in a range of countries, including the United States, Canada, Australia, Japan and India. Furthermore, the Company is a parent of Done Medical Oy, Kauhajoen Sisalogistiikka Oy, Icare Finland Oy, Oscare Medical Oy and Midas Touch Oy, among others.
Contact
IPO
Employees
Officers
The intrinsic value of one REG1V stock under the Base Case scenario is 30.94 EUR.
Compared to the current market price of 28.96 EUR, Revenio Group Oyj is Undervalued by 6%.